These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8097098)

  • 21. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human T-lymphotropic virus laboratory testing of maternal blood at time of cord blood donations and clinical implications.
    Glasser L; Cyrus S; Machan JT; Mapother J
    Transfusion; 2013 Jun; 53(6):1302-8. PubMed ID: 22998131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.
    Jõgeda EL; Avi R; Pauskar M; Kallas E; Karki T; Des Jarlais D; Uusküla A; Lutsar I; Huik K
    Infect Genet Evol; 2016 Sep; 43():83-5. PubMed ID: 27223634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses.
    Slattery JP; Franchini G; Gessain A
    Genome Res; 1999 Jun; 9(6):525-40. PubMed ID: 10400920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.
    Murphy EL; Watanabe K; Nass CC; Ownby H; Williams A; Nemo G
    J Infect Dis; 1999 Dec; 180(6):1777-83. PubMed ID: 10558931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
    Berini CA; Eirin ME; Pando MA; Biglione MM
    J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human T-cell lymphotrophic virus in California's injection drug users.
    Trachtenberg AI; Gaudino JA; Hanson CV
    J Psychoactive Drugs; 1991; 23(2):225-32. PubMed ID: 1765894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-lymphotropic virus types I and II.
    Rosenblatt JD
    West J Med; 1993 Apr; 158(4):379-84. PubMed ID: 7686315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroepidemiology of HTLV-I/II in Argentina: an overview.
    Gastaldello R; Hall WW; Gallego S
    J Acquir Immune Defic Syndr; 2004 Mar; 35(3):301-8. PubMed ID: 15076246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New horizons in HTLV-I and HTLV-II diagnosis.
    Lee HH
    Vox Sang; 1994; 67 Suppl 3():147-9. PubMed ID: 7975481
    [No Abstract]   [Full Text] [Related]  

  • 31. HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease.
    Soldan SS; Graf MD; Waziri A; Flerlage AN; Robinson SM; Kawanishi T; Leist TP; Lehky TJ; Levin MC; Jacobson S
    J Infect Dis; 1999 Sep; 180(3):685-94. PubMed ID: 10438355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HTLV-I and HTLV-II virus].
    Maniez-Montreuil M
    Ann Biol Clin (Paris); 1998; 56(5):563-70. PubMed ID: 9769480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of infection by HTLV-I/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece.
    Tseliou PM; Spanakis N; Spiliotakara A; Markogiannakis A; Legakis NJ; Tsakris A
    Int J STD AIDS; 2006 Aug; 17(8):543-6. PubMed ID: 16925902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of HTLV-I and HTLV-II infection in Honduras.
    Segurado A; Granade T; Parekh B; Nunez CA; Meza R; Amador L; Terrell S; George JR; Lal RB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(4):308. PubMed ID: 9402080
    [No Abstract]   [Full Text] [Related]  

  • 35. Seroprevalence and risk factors associated with HTLV-I/II infection in injection drug users in northern New Jersey.
    Freeman RC; Rodriguez GM; French JF
    J Addict Dis; 1995; 14(3):51-66. PubMed ID: 8555279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users.
    Lefrère F; Wattel E; Mariotti M; Agis F; Gordien E; Lefrère JJ
    J Infect Dis; 1992 Jul; 166(1):212-3. PubMed ID: 1607702
    [No Abstract]   [Full Text] [Related]  

  • 37. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
    Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
    West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden.
    Malm K; Ekermo B; Hillgren K; Britton S; Fredlund H; Andersson S
    Scand J Infect Dis; 2012 Nov; 44(11):852-9. PubMed ID: 22803699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain.
    Treviño A; Aguilera A; Caballero E; Toro C; Eiros JM; Ortiz de Lejarazu R; Rodríguez-Calviño JJ; Tuset C; Gómez-Hernando C; Rodríguez-Iglesias M; Ramos JM; Rodríguez-Díaz JC; Benito R; Trigo M; García-Campello M; Calderón E; Garcia J; Rodríguez C; Soriano V
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):551-4. PubMed ID: 19544594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-I and HTLV-II infections in volunteer blood donors and high-risk groups in Lebanon.
    Naman R; Klayme S; Naboulsi M; Mokhbat J; Jradi O; Ramia S
    J Infect; 2002 Jul; 45(1):29-31. PubMed ID: 12217728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.